Greenland Mines (NASDAQ: GRML) announced that its board of directors has adopted a limited-duration stockholder rights plan, effective July 22, 2026, designed to protect stockholders from coercive takeover tactics and ensure they receive full and fair value in connection with any proposal to acquire the company or obtain control. The rights plan will remain in effect for one year unless redeemed, exchanged, or otherwise terminated earlier.
Under the plan, rights generally become exercisable if a person or group acquires beneficial ownership of 15% or more of the company's outstanding common shares, with certain existing holders grandfathered under specified conditions. Greenland Mines stated that the plan is intended to provide the board with time to evaluate acquisition proposals and does not prevent it from considering or accepting offers determined to be in the best interests of stockholders.
The adoption of the rights plan comes as the company advances its multi-asset strategy, with operations spanning mining and biotech. The mining division focuses on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland. The biotech division includes Klotho's KLTO-202 primary indication for ALS. The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
For more details on the rights plan, see the full press release at https://ibn.fm/VilQp. The latest news and updates relating to GRML are available in the company's newsroom at https://ibn.fm/GRML.
This rights plan is a defensive measure that signals the board's commitment to protecting shareholder value, particularly as the company navigates strategic opportunities in the critical minerals and biotechnology sectors. It provides the board with leverage to negotiate from a position of strength should any unsolicited takeover attempts emerge. The one-year duration also gives the company time to execute its business plan without the distraction of hostile takeover bids.
Investors should note that forward-looking statements in this article involve risks, uncertainties, and other factors that may cause actual results to differ materially. These forward-looking statements are subject to a number of risks and uncertainties, including those set forth under the heading "Risk Factors" in the company's most recent Annual Report on Form 10-K and other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in making an investment decision.
